PCSK9 inhibition with alirocumab reduces lipoprotein(a) levels in nonhuman primates by lowering apolipoprotein(a) production rate.
暂无分享，去创建一个
M. Krempf | M. Croyal | G. Lambert | J. Le Bail | E. Villard | B. Poirier | P. Janiak | E. Guillot | C. Boixel | A. Aguesse | S. Billon-Crossouard | B. Nativel | S. Ramin-Mangata | V. Blanchard | I. Khantalin | K. Chémello | A. Thédrez | Thi-Thu-Trang Tran | R. Blanchard | K. Chemello | Elise F. Villard